Analyze Diet
Analytical and bioanalytical chemistry2014; 406(22); 5507-5512; doi: 10.1007/s00216-014-7944-z

A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses.

Abstract: In human medicine, procalcitonin (PCT) is a very common and well-established biomarker for sepsis. Even though sepsis is also a leading cause of death in foals and adult horses, up to now, no data about the role of equine PCT in septic horses has been available. Based on monoclonal antibodies targeted against human PCT, we report here the development of a sandwich ELISA for the quantification of equine PCT in equine plasma samples. The ELISA was characterized for intra- and interassay variance and a working range from 25 to 1,000 ng mL(-1) was defined as within this range; both intra- and interassay variances were below 15 %. The target recovery ranged between 73 and 106 %. The ELISA was used to determine the equine PCT concentration in 24 healthy and 5 septic horses to show the potential for clinical evaluation of equine PCT. Significantly different (P = 0.0006) mean equine PCT concentrations were found for the healthy control group and the sepsis group (47 and 8,450 ng mL(-1)).
Publication Date: 2014-06-14 PubMed ID: 24928115DOI: 10.1007/s00216-014-7944-zGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article presents the development of a new Enzyme-linked immunosorbent assay (ELISA) aimed at measuring the levels of procalcitonin, a biomarker for inflammation, in horses. The study has demonstrated a clear difference in procalcitonin concentrations between healthy horses and those with sepsis.

Development of Sandwich ELISA for Equine PCT

  • The researchers developed a new sandwich ELISA using monoclonal antibodies targeted against human PCT, but designed for the measurement of equine PCT in horse plasma samples.
  • This method was chosen due to its high specificity and sensitivity, which are important characteristics for a reliable diagnostic tool.
  • The ELISA devised for this research has a working range from 25 to 1,000 ng mL(-1). Any readings within this range are considered reliable, and this helps in reducing errors in the test results.

Characterization and Variance

  • The researchers evaluated the new ELISA based on two main criteria: intra-assay variance (the variability of results within a single test run) and interassay variance (the variability of results between separate test runs).
  • Both intra- and interassay variances for this ELISA fell below 15%, indicating a high level of precision and consistency in the assay’s measurements.
  • Additionally, the target recovery, or the amount of the initial analyte recovered after the testing, ranged between 73 and 106%, showcasing the test’s accuracy.

Evaluation of Equine PCT in Healthy and Septic Horses

  • The researchers used the newly developed ELISA to establish the PCT concentration in a total of 29 horses: 24 who were healthy, and 5 who had a confirmed case of sepsis.
  • Significant differences in PCT concentrations were found between the healthy control group and the sepsis group. The mean PCT concentrations for the healthy group was notably lower (47 ng mL(-1)) compared to the sepsis group (8,450 ng mL(-1)). This result strongly suggests the utility of the developed ELISA for identifying sepsis in horses.

Conclusion

This research shows promise in the application of the new ELISA for the diagnosis of sepsis and potentially other inflammatory conditions in horses. The developed test exhibits a high level of precision, accuracy, and consistency, which are essential properties for any diagnostic tool. The identification of significantly high PCT concentrations in septic horses compared to healthy ones further reinforces the potential of this tool. Further research and clinical testing are needed to completely validate its utility.

Cite This Article

APA
Rieger M, Kochleus C, Teschner D, Rascher D, Barton AK, Geerlof A, Kremmer E, Schmid M, Hartmann A, Gehlen H. (2014). A new ELISA for the quantification of equine procalcitonin in plasma as potential inflammation biomarker in horses. Anal Bioanal Chem, 406(22), 5507-5512. https://doi.org/10.1007/s00216-014-7944-z

Publication

ISSN: 1618-2650
NlmUniqueID: 101134327
Country: Germany
Language: English
Volume: 406
Issue: 22
Pages: 5507-5512

Researcher Affiliations

Rieger, Martin
  • Research Unit Microbe-Plant Interactions, Department of Environmental Sciences, Helmholtz Zentrum München, German Research Center for Environmental Health (GmbH), Ingolstädter Landstraße 1, 85764, Neuherberg, Germany, martin.rieger@helmholtz-muenchen.de.
Kochleus, Christian
    Teschner, Dana
      Rascher, Daniela
        Barton, Ann Kristin
          Geerlof, Arie
            Kremmer, Elisabeth
              Schmid, Michael
                Hartmann, Anton
                  Gehlen, Heidrun

                    MeSH Terms

                    • Animals
                    • Antibodies, Monoclonal / chemistry
                    • Biomarkers / blood
                    • Calcitonin / blood
                    • Calcitonin Gene-Related Peptide
                    • Enzyme-Linked Immunosorbent Assay / methods
                    • Female
                    • Horses
                    • Humans
                    • Inflammation
                    • Male
                    • Protein Precursors / blood
                    • ROC Curve
                    • Recombinant Proteins / chemistry
                    • Reproducibility of Results
                    • Sepsis / blood
                    • Sepsis / diagnosis

                    Citations

                    This article has been cited 17 times.
                    1. Fathi Ganje Lou E, Rezayan AH, Malekmohamadi M, Abbasi V, Molaabasi F. Very simple and ultra-sensitive fluorescence resonance energy transfer aptasensor for turn-on C-reactive protein detection in biological matrices. Sci Rep 2025 Oct 30;15(1):37996.
                      doi: 10.1038/s41598-025-21858-xpubmed: 41168329google scholar: lookup
                    2. Huang J, Zu Y, Zhang L, Cui W. Progress in Procalcitonin Detection Based on Immunoassay. Research (Wash D C) 2024;7:0345.
                      doi: 10.34133/research.0345pubmed: 38711476google scholar: lookup
                    3. Blangy-Letheule A, Vergnaud A, Dupas T, Rozec B, Lauzier B, Leroux AA. Spontaneous Sepsis in Adult Horses: From Veterinary to Human Medicine Perspectives. Cells 2023 Mar 30;12(7).
                      doi: 10.3390/cells12071052pubmed: 37048125google scholar: lookup
                    4. Qin D, Meng S, Wu Y, Luo Z, Deng B. Construction of efficient electrochemiluminescence resonance energy transfer sensor based on SnO(2)/SnS(2)QDs-Ru@IRMOF-3 composite for sensitive detection of procalcitonin. Mikrochim Acta 2022 Oct 21;189(11):430.
                      doi: 10.1007/s00604-022-05519-8pubmed: 36269425google scholar: lookup
                    5. Ning Q, Feng S, Cheng Y, Li T, Cui D, Wang K. Point-of-care biochemical assays using electrochemical technologies: approaches, applications, and opportunities. Mikrochim Acta 2022 Aug 2;189(8):310.
                      doi: 10.1007/s00604-022-05425-zpubmed: 35918617google scholar: lookup
                    6. Pang R, Zhu Q, Wei J, Wang Y, Xu F, Meng X, Wang Z. Development of a gold-nanorod-based lateral flow immunoassay for a fast and dual-modal detection of C-reactive protein in clinical plasma samples. RSC Adv 2021 Aug 16;11(45):28388-28394.
                      doi: 10.1039/d1ra04404dpubmed: 35480760google scholar: lookup
                    7. López-Martínez MJ, Escribano D, Martínez-Miró S, Ramis G, Manzanilla EG, Tecles F, Martínez-Subiela S, Cerón JJ. Measurement of procalcitonin in saliva of pigs: a pilot study. BMC Vet Res 2022 Apr 15;18(1):139.
                      doi: 10.1186/s12917-022-03240-5pubmed: 35428339google scholar: lookup
                    8. Meucci V, Orsetti C, Sgorbini M, Battaglia F, Cresci M, Bonelli F. Can Procalcitonin Be Dosed in Bovine Milk Using a Commercial ELISA Kit?. Animals (Basel) 2022 Jan 25;12(3).
                      doi: 10.3390/ani12030289pubmed: 35158613google scholar: lookup
                    9. Zhang N, Feng J, Zhao G, Duan X, Wang Y, Zhang D, Wei Q. Ultrasensitive Photochemical Immunosensor Based on Flowerlike SnO(2)/BiOI/Ag(2)S Composites for Detection of Procalcitonin. Biosensors (Basel) 2021 Oct 28;11(11).
                      doi: 10.3390/bios11110421pubmed: 34821637google scholar: lookup
                    10. Nocera I, Bonelli F, Vitale V, Meucci V, Conte G, Jose-Cunilleras E, Gracia-Calvo LA, Sgorbini M. Evaluation of Plasmatic Procalcitonin in Healthy, and in Systemic Inflammatory Response Syndrome (SIRS) Negative or Positive Colic Horses. Animals (Basel) 2021 Jul 6;11(7).
                      doi: 10.3390/ani11072015pubmed: 34359143google scholar: lookup
                    11. Akyüz E, Gökce G. Neopterin, procalcitonin, clinical biochemistry, and hematology in calves with neonatal sepsis. Trop Anim Health Prod 2021 Jun 9;53(3):354.
                      doi: 10.1007/s11250-021-02779-zpubmed: 34106342google scholar: lookup
                    12. Barton AK, Richter IG, Ahrens T, Merle R, Alalwani A, Lilge S, Purschke K, Barnewitz D, Gehlen H. MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic. Mediators Inflamm 2021;2021:9501478.
                      doi: 10.1155/2021/9501478pubmed: 33488296google scholar: lookup
                    13. Battaglia F, Meucci V, Tognetti R, Bonelli F, Sgorbini M, Lubas G, Pretti C, Intorre L. Procalcitonin Detection in Veterinary Species: Investigation of Commercial ELISA Kits. Animals (Basel) 2020 Aug 26;10(9).
                      doi: 10.3390/ani10091511pubmed: 32859059google scholar: lookup
                    14. Sheats MK. A Comparative Review of Equine SIRS, Sepsis, and Neutrophils. Front Vet Sci 2019;6:69.
                      doi: 10.3389/fvets.2019.00069pubmed: 30931316google scholar: lookup
                    15. Barton AK, Gehlen H. Pulmonary Remodeling in Equine Asthma: What Do We Know about Mediators of Inflammation in the Horse?. Mediators Inflamm 2016;2016:5693205.
                      doi: 10.1155/2016/5693205pubmed: 28053371google scholar: lookup
                    16. Barton AK, Pelli A, Rieger M, Gehlen H. Procalcitonin as a biomarker in equine chronic pneumopathies. BMC Vet Res 2016 Dec 9;12(1):281.
                      doi: 10.1186/s12917-016-0912-4pubmed: 27938364google scholar: lookup
                    17. Bonelli F, Meucci V, Divers TJ, Jose-Cunilleras E, Corazza M, Tognetti R, Guidi G, Intorre L, Sgorbini M. Plasma Procalcitonin Concentration in Healthy Horses and Horses Affected by Systemic Inflammatory Response Syndrome. J Vet Intern Med 2015 Nov-Dec;29(6):1689-91.
                      doi: 10.1111/jvim.13640pubmed: 26474412google scholar: lookup